Vote for Us as Your Favorite Emerging MedTech Co. Today!
MD+DI's editors narrowed the field of upstart medical device companies to sixteen. We will now face off against other companies tournament-style each week. There will be four voting rounds, with the last one ending on Monday, April 17. The winner will be profiled on MD+DI, a 35-year-old online and print publication leading the conversation in medical device development and manufacturing.
Top Company News:
Mar 18, 2016 - by James Cavuoto of NeuroTech Reports
When internet entrepreneur Bryan Johnson launched Kernel last year, he decided on a different approach from other neurotech firms. Rather than target a specific device for a specific disease, the company is more interested in building a broad technology platform that may prove useful in a number of applications down the road.... Johnson may not be the only entrepreneur interested in broadening neurotech’s reach. A recent article in theverge.com reports that Tesla CEO Elon Musk has begun putting together a team to explore the possibilities of human augmentation. And Nexeon MedSystems CEO Will Rosellini is reportedly a proponent of transhumanism, which foresees the day when man and machine meld to form a new species.
Feb 10, 2017 - by Niamh Marriott of European Pharmaceutical Review
The technology is astounding and has the potential to revolutionise the healthcare industry, give better treatment and diagnosis to patients, ensure productivity and communication within medical facilities and can provide personalised, targeted medicine. But what about the dangers, the privacy and security of information, and the risks to personal patient data? Do the benefits outweigh the risks? With IoT establishing itself in modern life, is IoMT the future of healthcare? We caught up with Nexeon’s CEO Will Rosellini to find out more…
Jan 24, 2017 - by Nick Ismail of Information Age
As smart devices connected by the Internet of Things become an increasing presence in homes and on the streets, the next stage is moving this technology to the healthcare system. In 2013, President Obama launched the BRAIN Initiative as a large-scale effort to equip researchers with insights necessary for treating a wide variety of brain disorders like Alzheimer’s, schizophrenia, autism, epilepsy, and traumatic brain injury. The World Health Organization estimates that devastating brain disorders affect more than one billion people worldwide.
Jan 23, 2017 - by Olivia Nguyen of DMagazine
"The Form 10 process has two immediate benefits," said Chairman and CEO Will Rosellini. "One, the financial transparency inherent in being a fully-reporting company will reveal our ongoing commitment to running lean operations and optimizing for our shareholder's return on equity. And secondly... I'm confident that a slow approach to a registered public offering offers a better opportunity for our existing and new shareholders."